Study Shows Expansion of Stem Cell Clinics in the U.S. and the Need for Better Oversight
Researchers have published a paper describing the proliferation of stem cell clinics in the United States and ethical issues and regulatory concerns that come with marketing unproven treatments for many conditions. Their study shows that many different types of unproven stem cell treatments are being offered, and highlights concerns for the safety of people who undergo these treatments.
There is exciting progress being made through innovative research related to the potential of many types of stem cells for slowing MS disease activity and for repairing damage to the nervous system. At present, there are no approved stem cell therapies for MS. People need the best available information to understand this exciting area of research and make decisions related to this complex issue.
The paper’s findings support the need for stem cell therapy to be explored in the context of carefully conducted clinical trials that can determine what the optimal cells, delivery methods, safety and actual effectiveness of cell therapies might be for people with MS.
- Read a news story about this article in Scientific American: Unproven Stem Cell Clinics Proliferate in the U.S.
- Read the original journal paper in Cell Stem Cell: Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry
- Read more about stem cells and MS, and Stem Cell Clinics